Novartis announced FDA approval for Fabhalta
Go back to Novartis announced FDA approval for Fabhalta| NOVARTIS AG (NYSE: NVS) | Delayed: 154.77 +1.50 (0.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $153.27 | 52 Week High | $89.15 | |||
| Open | $155.23 | 52 Week Low | $69.84 | |||
| Day High | $155.56 | P/E | N/A | |||
| Day Low | $153.81 | EPS | $0.00 | |||
| Volume | 351,575 | |||||
